These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 17470841)
1. Blood products for Spanish influenza: a future H5N1 treatment? Logtenberg SJ; Bilo HJ Ann Intern Med; 2007 May; 146(9):686-7; author reply 687. PubMed ID: 17470841 [No Abstract] [Full Text] [Related]
2. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Luke TC; Kilbane EM; Jackson JL; Hoffman SL Ann Intern Med; 2006 Oct; 145(8):599-609. PubMed ID: 16940336 [TBL] [Abstract][Full Text] [Related]
3. Avian influenza: exploring all the avenues. Treanor JJ Ann Intern Med; 2006 Oct; 145(8):631-2. PubMed ID: 16940335 [No Abstract] [Full Text] [Related]
4. Immunology. Flu antibodies stir new hope for treatment, vaccine. Leslie M Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602 [No Abstract] [Full Text] [Related]
5. Treatment with convalescent plasma for influenza A (H5N1) infection. Zhou B; Zhong N; Guan Y N Engl J Med; 2007 Oct; 357(14):1450-1. PubMed ID: 17914053 [No Abstract] [Full Text] [Related]
6. An addition to treatment options for avian influenza A H5N1? Baz M; Subbarao K Lancet Infect Dis; 2015 Mar; 15(3):251-3. PubMed ID: 25662593 [No Abstract] [Full Text] [Related]
7. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1. Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097 [TBL] [Abstract][Full Text] [Related]
8. [Human monoclonal antibodies in preventive and therapeutic use against H5N1 virus]. Nau JY Rev Med Suisse; 2007 Jun; 3(115):1549. PubMed ID: 17682803 [No Abstract] [Full Text] [Related]
9. [Influenza virus, human: two avenues for the new treatment]. Casselyn M Rev Med Suisse; 2009 Mar; 5(194):605. PubMed ID: 19405281 [No Abstract] [Full Text] [Related]
10. Successful treatment of avian influenza with convalescent plasma. Kong LK; Zhou BP Hong Kong Med J; 2006 Dec; 12(6):489. PubMed ID: 17148811 [No Abstract] [Full Text] [Related]
11. Clinical preparedness for severe pneumonia with highly pathogenic avian influenza A (H5N1): experiences with cases in Vietnam. Kudo K; Binh NG; Manabe T; Co DX; Tuan ND; Izumi S; Takasaki J; Minh DH; Thuy PT; Van VT; Hanh TT; Chau NQ Respir Investig; 2012 Dec; 50(4):140-50. PubMed ID: 23199978 [TBL] [Abstract][Full Text] [Related]
12. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza. Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza. Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095 [TBL] [Abstract][Full Text] [Related]
14. [Trends in and challenges for highly pathogenic avian influenza A (H5N1)]. Kudo K; Manabe T; Izumi S; Takasaki J Nihon Rinsho; 2010 Sep; 68(9):1736-42. PubMed ID: 20845757 [TBL] [Abstract][Full Text] [Related]
16. [Noninvasive ventilation in pneumonia due to N1H1 virus]. Gómez Grande ML Med Intensiva; 2011 Nov; 35(8):457-9. PubMed ID: 21722992 [No Abstract] [Full Text] [Related]
18. Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir. Herbreteau CH; Denizot M; Lowther S; Riddell S; Frazer L; Haining J; Arkinstall R; Payne J; Harper J; Johnson D; Pasquier A; Middleton D; Saluzzo JF Immunotherapy; 2016 Sep; 8(9):1021-32. PubMed ID: 27380317 [TBL] [Abstract][Full Text] [Related]
19. Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination. van Maurik A; Sabarth N; Dacho HS; Brühl P; Schwendinger M; Crowe BA; Noel Barrett P; Kistner O; Keith Howard M Vaccine; 2010 Feb; 28(7):1778-85. PubMed ID: 20018265 [TBL] [Abstract][Full Text] [Related]
20. Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments. Ramisse F; Deramoudt FX; Szatanik M; Bianchi A; Binder P; Hannoun C; Alonso JM Clin Exp Immunol; 1998 Mar; 111(3):583-7. PubMed ID: 9528903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]